Please Note:
This profile was automatically generated using 102 references found on the Internet. This information has not been verified. Learn more...
This profile was automatically generated using 102 references found on the Internet. This information has not been verified. Learn more...
View all 102 references Web References
-
1. www.pharmanet-usa.com
www.pharmanet-usa.com/aboutus/ - [Cached]Published on: 5/19/2008 Last Visited: 5/19/2008
Johane Boucher-Champagne, DSA
President, Anapharm and Executive Vice President, Early Stage Development
Ms. Boucher-Champagne was appointed Executive Vice President, Early Clinical Development in March 2006 and was also named president and chief executive officer of Anapharm, Inc., a subsidiary to PharmaNet, in February 2007.Ms. Boucher-Champagne holds an Executive Master's Degree in Administration and a degree in life sciences.She has more than thirty years of experience with health-science research activities, business management and administration. -
2. www.pharmanet-cro.com
www.pharmanet-cro.com/aboutus/ - [Cached]Published on: 5/19/2008 Last Visited: 5/19/2008
Johane Boucher-Champagne, DSA
President, Anapharm and Executive Vice President, Early Stage Development
Ms. Boucher-Champagne was appointed Executive Vice President, Early Clinical Development in March 2006 and was also named president and chief executive officer of Anapharm, Inc., a subsidiary to PharmaNet, in February 2007.Ms. Boucher-Champagne holds an Executive Master's Degree in Administration and a degree in life sciences.She has more than thirty years of experience with health-science research activities, business management and administration. -
3. Anapharm
www.anapharm.com/site/client/e - [Cached]Published on: 3/20/2008 Last Visited: 3/20/2008
Johane Boucher-Champagne President and Chief Executive Officer A graduate of the École de hautes études commerciales de Montréal, Johane has wide-ranging experience with health-science research activities as well as expertise and experience in business management and administration. She began working at Anapharm as its chief operating officer in 1998. She has since helped manage its rapid growth by taking over different corporate duties and by introducing participation-based management. Since the beginning of her career, she has worked at university research centres and contract research firms. She was involved on many occasions in setting up biological analysis laboratories and in starting up research groups on animal and human metabolism. In addition, as Business Development Manager, she had successfully helped promote the services of a new Canadian research firm within the global community of the pharmaceutical industry.

